TORONTO, ONTARIO--(Marketwired - Dec. 23, 2013) - Mr. Ian Ihnatowycz, announced today that he acquired 6,600,000 common shares of Trimel Pharmaceuticals Corporation (the "Issuer") at $0.33 per share through his private investment holding company First Generation Capital Inc. The purchase was made on the Canadian public markets.